INSIGHT (Isothermal NASBA-Sequencing-based hIGH-througput Test) is a two-stage COVID-19 testing strategy, using a barcoded isothermal NASBA reaction that combines point-of-care diagnosis with next generation sequencing, aiming to achieve population-scale COVID-19 testing. We are aiming to making COVID-19 diagnosis simple, scalable and cost-effective in order to achieve regular population scale testing. This is an ongoing project and we are currently working with UK BioResource to validate our test using clinical samples. Please contact us if you are interested in the technology (insight@sanger.ac.uk).
*** This is ongoing academic research to develop a testing strategy for the SARS-CoV-2 virus. The Wellcome Sanger Institute Tech Transfer Office is keen to engage with third parties to explore development of the testing protocol to achieve the societal benefits of this research EMAIL HERE.
*** DISCLAIMER: This protocol has not been validated on patient samples and should not be used for clinical diagnosis without further validation and certification.